Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic

Bryan Greenhouse, Benjamin Ho, Alan Hubbard, Denise Njama-Meya, David L. Narum, David E. Lanar, Sheetij Dutta, Philip J. Rosenthal, Grant Dorsey, Chandy John

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Background. Associations between antibody responses to Plasmodium falciparum antigens and protection against symptomatic malaria have been difficult to ascertain, in part because antibodies are potential markers of both exposure to P. falciparum and protection against disease. Methods. We measured IgG responses to P. falciparum circumsporozoite protein, liver-stage antigen 1, apicalmembrane antigen 1 (AMA-1), and merozoite surface proteins (MSP) 1 and 3, in children in Kampala, Uganda, and measured incidence of malaria before and after antibody measurement. Results. Stronger responses to all 5 antigens were associated with an increased risk of clinical malaria (P <.01) because of confounding with prior exposure to P. falciparum. However, with use of another assessment, risk of clinical malaria once parasitemic, stronger responses to AMA-1, MSP-1, and MSP-3 were associated with protection (odds ratios, 0.34, 0.36, and 0.31, respectively, per 10-fold increase; P <.01). Analyses assessing antibodies in combination suggested that any protective effect of antibodies was overestimated by associations between individual responses and protection. Conclusions. Using the risk of symptomatic malaria once parasitemic as an outcome may improve detection of associations between immune responses and protection from disease. Immunoepidemiology studies designed to detect mechanisms of immune protection should integrate prior exposure into the analysis and evaluate multiple immune responses.

Original languageEnglish (US)
Pages (from-to)19-26
Number of pages8
JournalJournal of Infectious Diseases
Volume204
Issue number1
DOIs
StatePublished - Jul 1 2011
Externally publishedYes

Fingerprint

Plasmodium falciparum
Malaria
Antigens
Merozoite Surface Protein 1
Antibodies
Merozoites
Uganda
Antibody Formation
Membrane Proteins
Immunoglobulin G
Odds Ratio
Liver
Incidence

ASJC Scopus subject areas

  • Infectious Diseases
  • Immunology and Allergy

Cite this

Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic. / Greenhouse, Bryan; Ho, Benjamin; Hubbard, Alan; Njama-Meya, Denise; Narum, David L.; Lanar, David E.; Dutta, Sheetij; Rosenthal, Philip J.; Dorsey, Grant; John, Chandy.

In: Journal of Infectious Diseases, Vol. 204, No. 1, 01.07.2011, p. 19-26.

Research output: Contribution to journalArticle

Greenhouse, B, Ho, B, Hubbard, A, Njama-Meya, D, Narum, DL, Lanar, DE, Dutta, S, Rosenthal, PJ, Dorsey, G & John, C 2011, 'Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic', Journal of Infectious Diseases, vol. 204, no. 1, pp. 19-26. https://doi.org/10.1093/infdis/jir223
Greenhouse, Bryan ; Ho, Benjamin ; Hubbard, Alan ; Njama-Meya, Denise ; Narum, David L. ; Lanar, David E. ; Dutta, Sheetij ; Rosenthal, Philip J. ; Dorsey, Grant ; John, Chandy. / Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic. In: Journal of Infectious Diseases. 2011 ; Vol. 204, No. 1. pp. 19-26.
@article{f24d9973c8de4b54bad3fb741b75bb82,
title = "Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic",
abstract = "Background. Associations between antibody responses to Plasmodium falciparum antigens and protection against symptomatic malaria have been difficult to ascertain, in part because antibodies are potential markers of both exposure to P. falciparum and protection against disease. Methods. We measured IgG responses to P. falciparum circumsporozoite protein, liver-stage antigen 1, apicalmembrane antigen 1 (AMA-1), and merozoite surface proteins (MSP) 1 and 3, in children in Kampala, Uganda, and measured incidence of malaria before and after antibody measurement. Results. Stronger responses to all 5 antigens were associated with an increased risk of clinical malaria (P <.01) because of confounding with prior exposure to P. falciparum. However, with use of another assessment, risk of clinical malaria once parasitemic, stronger responses to AMA-1, MSP-1, and MSP-3 were associated with protection (odds ratios, 0.34, 0.36, and 0.31, respectively, per 10-fold increase; P <.01). Analyses assessing antibodies in combination suggested that any protective effect of antibodies was overestimated by associations between individual responses and protection. Conclusions. Using the risk of symptomatic malaria once parasitemic as an outcome may improve detection of associations between immune responses and protection from disease. Immunoepidemiology studies designed to detect mechanisms of immune protection should integrate prior exposure into the analysis and evaluate multiple immune responses.",
author = "Bryan Greenhouse and Benjamin Ho and Alan Hubbard and Denise Njama-Meya and Narum, {David L.} and Lanar, {David E.} and Sheetij Dutta and Rosenthal, {Philip J.} and Grant Dorsey and Chandy John",
year = "2011",
month = "7",
day = "1",
doi = "10.1093/infdis/jir223",
language = "English (US)",
volume = "204",
pages = "19--26",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic

AU - Greenhouse, Bryan

AU - Ho, Benjamin

AU - Hubbard, Alan

AU - Njama-Meya, Denise

AU - Narum, David L.

AU - Lanar, David E.

AU - Dutta, Sheetij

AU - Rosenthal, Philip J.

AU - Dorsey, Grant

AU - John, Chandy

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Background. Associations between antibody responses to Plasmodium falciparum antigens and protection against symptomatic malaria have been difficult to ascertain, in part because antibodies are potential markers of both exposure to P. falciparum and protection against disease. Methods. We measured IgG responses to P. falciparum circumsporozoite protein, liver-stage antigen 1, apicalmembrane antigen 1 (AMA-1), and merozoite surface proteins (MSP) 1 and 3, in children in Kampala, Uganda, and measured incidence of malaria before and after antibody measurement. Results. Stronger responses to all 5 antigens were associated with an increased risk of clinical malaria (P <.01) because of confounding with prior exposure to P. falciparum. However, with use of another assessment, risk of clinical malaria once parasitemic, stronger responses to AMA-1, MSP-1, and MSP-3 were associated with protection (odds ratios, 0.34, 0.36, and 0.31, respectively, per 10-fold increase; P <.01). Analyses assessing antibodies in combination suggested that any protective effect of antibodies was overestimated by associations between individual responses and protection. Conclusions. Using the risk of symptomatic malaria once parasitemic as an outcome may improve detection of associations between immune responses and protection from disease. Immunoepidemiology studies designed to detect mechanisms of immune protection should integrate prior exposure into the analysis and evaluate multiple immune responses.

AB - Background. Associations between antibody responses to Plasmodium falciparum antigens and protection against symptomatic malaria have been difficult to ascertain, in part because antibodies are potential markers of both exposure to P. falciparum and protection against disease. Methods. We measured IgG responses to P. falciparum circumsporozoite protein, liver-stage antigen 1, apicalmembrane antigen 1 (AMA-1), and merozoite surface proteins (MSP) 1 and 3, in children in Kampala, Uganda, and measured incidence of malaria before and after antibody measurement. Results. Stronger responses to all 5 antigens were associated with an increased risk of clinical malaria (P <.01) because of confounding with prior exposure to P. falciparum. However, with use of another assessment, risk of clinical malaria once parasitemic, stronger responses to AMA-1, MSP-1, and MSP-3 were associated with protection (odds ratios, 0.34, 0.36, and 0.31, respectively, per 10-fold increase; P <.01). Analyses assessing antibodies in combination suggested that any protective effect of antibodies was overestimated by associations between individual responses and protection. Conclusions. Using the risk of symptomatic malaria once parasitemic as an outcome may improve detection of associations between immune responses and protection from disease. Immunoepidemiology studies designed to detect mechanisms of immune protection should integrate prior exposure into the analysis and evaluate multiple immune responses.

UR - http://www.scopus.com/inward/record.url?scp=79957928865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957928865&partnerID=8YFLogxK

U2 - 10.1093/infdis/jir223

DO - 10.1093/infdis/jir223

M3 - Article

VL - 204

SP - 19

EP - 26

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 1

ER -